Synaptics (SYNA) director awarded 3,036 shares; holds 10,958
Synaptics Inc. (SYNA) disclosed a director equity transaction on Form 4.
Rhea-AI Filing Summary
Synaptics Inc. (SYNA) disclosed a director equity transaction on Form 4. On 11/03/2025, the director acquired 3,036 shares of common stock at $0 per share under an equity award, bringing total directly held shares to 10,958.
The award reflects restricted stock units (RSUs) that vest in quarterly installments, with full vesting by November 3, 2026, or for a director not standing for re-election, on the date of the company’s 2026 Annual Meeting of Stockholders. No derivative securities were reported in Table II.
Positive
- None.
Negative
- None.
Insights
Routine director RSU grant; neutral governance event.
Synaptics reported a director’s acquisition of 3,036 common shares at $0, consistent with equity compensation. Post‑transaction direct holdings are 10,958 shares.
The filing notes RSUs vest quarterly until fully vested by November 3, 2026, or at the 2026 annual meeting for a director not standing for re‑election. This cadence aligns with typical board compensation structures.
As a non-cash award and standard governance practice, this is not thesis-changing. Any impact depends on ongoing board service and standard vesting mechanics.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,036 | $0.00 | $0.00 |
Footnotes (1)
- F1. One-fourth of the total number of restricted stock units shall vest each quarter until fully vested on November 3, 2026, or for a Director not standing for re-election, the date of the Issuer's 2026 Annual Meeting of Stockholders.
FAQ
What did Synaptics (SYNA) report in this Form 4?
What is the vesting schedule for the RSUs reported by SYNA?
What was the transaction code in the SYNA Form 4?
Were any derivative securities reported for SYNA in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.